BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 15702884)

  • 1. [PPARs: the role in glucose and lipid homeostasis, insulin resistance and atherosclerosis].
    Hrebícek J
    Cesk Fysiol; 2004; 53(1):4-16. PubMed ID: 15702884
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Peroxisome proliferator activated receptors (PPAR) and insulin sensitivity: experimental studies].
    Haluzík MM; Haluzík M
    Cesk Fysiol; 2006; 55(4):163-8. PubMed ID: 17685022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Be fit or be sick: peroxisome proliferator-activated receptors are down the road.
    Desvergne B; Michalik L; Wahli W
    Mol Endocrinol; 2004 Jun; 18(6):1321-32. PubMed ID: 15087471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The metabolic syndrome: relationship between insulin sensitivity and the role of peroxisome proliferator-activated receptors (PPARs) in saccharide and lipid metabolism.
    Yahia RB; Lichnovská R; Brychta T
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2005 Dec; 149(2):237-41. PubMed ID: 16601762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PPARs and the orchestration of metabolic fuel selection.
    Sugden MC; Zariwala MG; Holness MJ
    Pharmacol Res; 2009 Sep; 60(3):141-50. PubMed ID: 19646653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Recent advances in PPARs research--basic and clinical aspects].
    Kadowaki T
    Nihon Rinsho; 2005 Apr; 63(4):539-48. PubMed ID: 15828218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The structures and functions of peroxisome proliferator-activated receptors (PPARs)].
    Takahashi N; Goto T; Kusudo T; Moriyama T; Kawada T
    Nihon Rinsho; 2005 Apr; 63(4):557-64. PubMed ID: 15828220
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The role of PPARs and their isoforms in metabolic disorders related to insulin resistance and diabetes].
    Kravchenko NA; Iarmysh NV
    Tsitol Genet; 2011; 45(3):68-78. PubMed ID: 21774406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Peroxisome proliferator-activated receptors (PPARs) in obesity and insulin resistance development].
    Alemán G; Torres N; Tovar AR
    Rev Invest Clin; 2004; 56(3):351-67. PubMed ID: 15612519
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Regulation of fat metabolism by PPARs].
    Liu XF; Li H
    Yi Chuan; 2006 Feb; 28(2):243-8. PubMed ID: 16520324
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PPARs: fatty acid sensors controlling metabolism.
    Poulsen Ll; Siersbæk M; Mandrup S
    Semin Cell Dev Biol; 2012 Aug; 23(6):631-9. PubMed ID: 22273692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peroxisome proliferator-activated receptors (PPARs): nuclear receptors at the crossroads between lipid metabolism and inflammation.
    Chinetti G; Fruchart JC; Staels B
    Inflamm Res; 2000 Oct; 49(10):497-505. PubMed ID: 11089900
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The selected pathophysiological aspects of PPARs activation.
    Kieć-Wilk B; Dembińska-Kieć A; Olszanecka A; Bodzioch M; Kawecka-Jaszcz K
    J Physiol Pharmacol; 2005 Jun; 56(2):149-62. PubMed ID: 15985699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [PPAR and diabetes].
    Terauchi Y; Kadowaki T
    Nihon Rinsho; 2005 Apr; 63(4):623-9. PubMed ID: 15828230
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PPARs-Orchestrated Metabolic Homeostasis in the Adipose Tissue.
    Sun C; Mao S; Chen S; Zhang W; Liu C
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peroxisome proliferator-activated receptors and the metabolic syndrome.
    Bragt MC; Popeijus HE
    Physiol Behav; 2008 May; 94(2):187-97. PubMed ID: 18191967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug Insight: mechanisms of action and therapeutic applications for agonists of peroxisome proliferator-activated receptors.
    Gervois P; Fruchart JC; Staels B
    Nat Clin Pract Endocrinol Metab; 2007 Feb; 3(2):145-56. PubMed ID: 17237841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The vascular biology of peroxisome proliferator-activated receptors: modulation of atherosclerosis.
    Verma S; Szmitko PE
    Can J Cardiol; 2006 Feb; 22 Suppl B(Suppl B):12B-17B. PubMed ID: 16498507
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pleiotropic Actions of Peroxisome Proliferator-Activated Receptors (PPARs) in Dysregulated Metabolic Homeostasis, Inflammation and Cancer: Current Evidence and Future Perspectives.
    Laganà AS; Vitale SG; Nigro A; Sofo V; Salmeri FM; Rossetti P; Rapisarda AM; La Vignera S; Condorelli RA; Rizzo G; Buscema M
    Int J Mol Sci; 2016 Jun; 17(7):. PubMed ID: 27347932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An overview on biological mechanisms of PPARs.
    Kota BP; Huang TH; Roufogalis BD
    Pharmacol Res; 2005 Feb; 51(2):85-94. PubMed ID: 15629253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.